
Tennessee executes man with implanted heart device despite concerns over shock risk
Byron Black was executed after a back-and-forth in court over whether officials would need to turn off his implantable cardioverter-defibrillator, or ICD.
Gov. Bill Lee declined Monday to grant a reprieve, clearing the way for Black's execution after a legal battle and ongoing uncertainty about whether the implantable cardioverter-defibrillator will shock his heart when the lethal drug takes effect.
The nonprofit Death Penalty Information Center said it was unaware of any other cases in which a person on death row made similar claims to Black's about defibrillators or pacemakers. Black's attorneys said they had not found a comparable case, either.
Lee said the courts "universally determined that it is lawful to carry out the jury's sentence of execution given to Mr. Black for the heinous murders of Angela Clay and her daughters Lakeisha, age 6, and Latoya, age 9."
The U.S. Supreme Court on Monday rejected Black's appeals. The execution was Tennessee's second since May, after a pause for five years, first because of COVID-19 and then because of missteps by state corrections officials.
Twenty-eight men have died by court-ordered execution so far this year in the U.S., exceeding the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death.
According to the Death Penalty Information Center, Tennessee has 46 inmates on death row. The state has granted clemency three times.
Black, 69, was in a wheelchair, and he had dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys had said.
His implantable cardioverter-defibrillator is a small, battery-powered electronic device that is surgically implanted in the chest. It served as a pacemaker and an emergency defibrillator. Black's attorneys said in order to be sure it was off, a doctor would have to place a programming device over the implant site, sending it a deactivation command, with no surgery required.
In mid-July, a trial court judge agreed with Black's attorneys that officials must have his device deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state Supreme Court intervened July 31 to overturn that decision, saying the other judge lacked the authority to order the change.
The state had disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state said.
Black's attorneys had countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain.
Kelley Henry, Black's attorney, said previously that the execution could become a "grotesque spectacle." According to the Tennessee Department of Corrections, seven media members had been selected witnesses to the execution at the Riverbend Maximum Security Institution.
The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics.
Black was convicted in the 1988 shooting deaths of girlfriend Angela Clay, 29, and her two daughters, Latoya, 9, and Lakeisha, 6. Prosecutors said Black was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting and wounding Clay's estranged husband.
Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: "He didn't have mercy on them, so why should we have mercy on him?"
Black had already seen three execution dates come and go, due to the COVID-19 pandemic and a pause on executions after the Department of Correction was found to not be testing the execution drugs for potency and purity as required.
In recent years, Black's legal team unsuccessfully tried to get a new hearing over whether he was intellectually disabled and ineligible for the death penalty under U.S. Supreme Court precedent.
His attorneys said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law.
Last month, Black's lawyers sent a letter to Tennessee's governor, urging him to grant Black clemency and asking him to commute his sentence to life in prison.
"Mr. Black, who lives with an intellectual disability, has been on death row for 25 years," the letter read. "From infancy, he suffered from the effects of prenatal alcohol exposure, resulting in Fetal Alcohol Syndrome. As a toddler, he was exposed to toxic lead, compounding his lifelong cognitive and developmental impairments."
Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserved a hearing under that 2021 law, but the judge denied it. That is because the 2021 law denies a hearing to people on death row who have already filed a similar request and a court has ruled on it "on the merits."
In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called "mental retardation." But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability.
Black also sought a determination by the courts that he was incompetent to be executed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
3 minutes ago
- Yahoo
At Least 1 Dead, Multiple Injured After U.S. Steel Plant Explodes, Authorities Say
Aerial footage appeared to show serious structural damage following the Pennsylvania blast on Aug. 11NEED TO KNOW At least one person is dead, and others have been injured after the U.S. Steel Clairton Coke Works plant exploded in Pennsylvania on Monday, Aug. 11 A spokesperson for the Allegheny County Department of Emergency Services confirmed to PEOPLE there has been one fatality, while multiple individuals have been injured Two people are believed to be unaccounted for, according to the Allegheny County Emergency Services DepartmentAt least one person has died and others are injured after an explosion at a steel plant in Pennsylvania, authorities said. Emergency workers are responding to the deadly explosion at the U.S. Steel Clairton Coke Works plant in Clairton, Penn., Kasey Reigner, a public information officer for the Allegheny County Department of Emergency Services, said in a statement to PEOPLE. At least one person has been killed in the incident, Reigner added. Their identity has not been released at this time. Allegheny County Emergency Services and Allegheny County Police are currently on scene investigating, she said. It was not immediately clear what caused the blast. Reigner said the scene remains active and the public is asked to avoid the area. "Two people are currently believed to be unaccounted for, and multiple individuals have been treated for additional injuries. The status of those individuals is not known at this time," Reigner said. Dark grey smoke could be seen billowing as the explosion occurred during a time-lapse video shared by ABC affiliate WTAE. Aerial footage from the station appeared to show serious structural damage in the aftermath of the blast. "My administration is in touch with local officials in Clairton, PA as they respond to an explosion at US Steel Clairton Coke Works plant this morning," Penn. Gov. Josh Shapiro said in a post on X, adding that the Pennsylvania Emergency Management Agency and state police are in touch with first responders. "The scene is still active, and folks nearby should follow the direction of local authorities. Please join Lori and me in praying for the Clairton community." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Zachary Buday told WTAE he was working nearby when the incident occurred. "Felt like thunder. Shook the scaffold, shook my chest, then shook the building. Then we saw the smoke coming up from the steel mill," Buday told the station. Read the original article on People


Medscape
4 minutes ago
- Medscape
FDA Okays Ketamine-Based Med for Post-Surgical Pain
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical pain. 'This historic FDA approval…is a testament to years of dedicated development,' Fabio Chianelli, chairman and CEO of PharmaTher, said in a release. 'We remain steadfast in our mission to harness the pharmaceutical potential of ketamine for a range of mental health, neurological, and pain disorders,' he added. The company noted that it hopes to expand ketamine development into conditions such as Parkinson's disease, amyotrophic lateral sclerosis, depression, and complex regional pain syndrome. Its product has already received an orphan drug designation for the treatment of Rett syndrome. It added that, among psychedelic and 'psychedelic-adjacent' drugs, ketamine is the only one to be included on a list of Essential Medicines by the World Health Organization. The company initially announced that the FDA had set an approval goal date of April 2024 for KETARx. However, after 'minor deficiencies identified by Quality' were identified, the FDA assigned a new target date of October 2024. As reported by Medscape Medical News at the time, the FDA issued a complete response letter requesting additional information on the application. The final date of August 2025 was set after the company submitted the requested additional information.


Gizmodo
4 minutes ago
- Gizmodo
Handsoaps Recalled Over Bacteria That Can Cause Sepsis
Four brands of soap and skin products are being recalled by their manufacturer after they were discovered to potentially be contaminated with bacteria that can cause infections, and even lead to sepsis in immunosuppressed people, according to announcements from the FDA and DermaRite Industries. The products, DermaKleen, KleenFoam, DermaSarra, and PeriGiene, have been recalled nationwide in the U.S. and Puerto Rico over the bacteria Burkholderia cepacia (spelled as cepecia in the FDA press release), though the health agency didn't indicate how the contamination of the soaps may have occurred. The announcements from the FDA and DermaRite Industries also didn't state where the soaps and skin products were sold, though listings online suggest the soaps are often purchased by companies and institutions for use in public facilities. It's not clear how popular the products may be at physical retail stores where the average consumer might buy them for use in the home, though they are available at online retailers like Amazon. Neither DermaRite nor the FDA immediately responded to questions Monday. The FDA's description of the recalled products: 'In healthy individuals with minor skin lesions the use of the product will more likely result in local infections, whereas in immunocompromised individuals the infection is more likely to spread into blood stream leading to life-threatening sepsis,' the company said in a statement posted online. 'To date, DermaRite has not received any reports of adverse events related to this recall.' Consumers who believe they're experiencing issues after using these products are encouraged to contact their doctors. The lot numbers and expiration dates for the recalled products, according to DermaRite: Consumers who have questions about the recall are encouraged to call Mary Goldberg at DermaRite Industries at the number 973-569-9000 x104, Monday through Friday, from 9:00 am to 5:00 pm ET, according to the company's press release. The company can also be reached by email at: [email protected].